Treace Medical Concepts, Inc.
General ticker "TMCI" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $296.0M (TTM average)
Treace Medical Concepts, Inc. does not follow the US Stock Market performance with the rate: -16.0%.
Estimated limits based on current volatility of 4.7%: low 3.32$, high 3.65$
Factors to consider:
- Total employees count: 477 (-7.6%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Reimbursement risks affecting product adoption, Market competition, Uncertain profitability, Operational and conduct risks, Cybersecurity threats
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.97$, 5.78$]
- 2026-12-31 to 2027-12-31 estimated range: [1.92$, 5.44$]
Financial Metrics affecting the TMCI estimates:
- Positive: with PPE of -2.7 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Investing cash flow per share per price, % of 8.46 > -0.60
- Positive: 42.59 < Shareholder equity ratio, % of 45.82 <= 64.29
- Positive: Inventory ratio change, % of -1.30 <= -0.75
- Positive: Industry inventory ratio change (median), % of -0.30 <= -0.16
Short-term TMCI quotes
Long-term TMCI plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $187.12MM | $209.36MM | $212.69MM |
| Operating Expenses | $238.55MM | $265.05MM | $266.84MM |
| Operating Income | $-51.43MM | $-55.69MM | $-54.15MM |
| Non-Operating Income | $1.90MM | $-0.06MM | $-4.85MM |
| Interest Expense | $5.17MM | $5.26MM | $5.32MM |
| R&D Expense | $15.44MM | $20.59MM | $20.28MM |
| Income(Loss) | $-49.53MM | $-55.74MM | $-59.00MM |
| Net Income(Loss)* | $-49.53MM | $-55.74MM | $-59.00MM |
| Stockholders Equity | $137.94MM | $112.89MM | $87.33MM |
| Inventory | $29.25MM | $39.26MM | $36.03MM |
| Assets | $251.91MM | $217.09MM | $190.58MM |
| Operating Cash Flow | $-34.58MM | $-37.17MM | $-15.97MM |
| Capital expenditure | $11.46MM | $11.59MM | $13.52MM |
| Investing Cash Flow | $-81.30MM | $35.38MM | $13.25MM |
| Financing Cash Flow | $109.38MM | $0.16MM | $2.08MM |
| Earnings Per Share** | $-0.81 | $-0.90 | $-0.93 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.